July 14, 2015

EGRIFTATM (Tesamorelin for Injection) Approved in Mexico

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that COFEPRIS, Mexico’s health agency, has approved the 2mg/vial presentation of tesamorelin for the treatment of lipodystrophy.